New medical conditions added to program 

The Minnesota Department of Health will add irritable bowel syndrome and obsessive-compulsive disorder to the list of qualifying medical conditions for […]

A person holding their hands on their stomach with a red transparent circle showing a pain spot.

The Minnesota Department of Health will add irritable bowel syndrome and obsessive-compulsive disorder to the list of qualifying medical conditions for participation in Minnesota’s medical cannabis program. The new qualifying conditions will take effect August 1, 2023. 

“We are adding the new qualifying conditions to allow patients more therapy options for conditions that can be debilitating,” said Minnesota Commissioner of Health Jan Malcolm. 

Irritable bowel syndrome (IBS) is a disorder characterized by abdominal pain or discomfort, and irregular bowel movements that can result in diarrhea, constipation, both diarrhea and constipation, or bloating. Obsessive-compulsive disorder (OCD) is characterized by recurring, intrusive thoughts that often cause significant emotional distress and anxiety. This can lead to behaviors that the affected person feels compelled to perform to reduce that distress. Research has shown that people who suffer from these conditions can see benefits from using medical cannabis to treat their symptoms. 
As in past years, state officials conducted a formal petition process to solicit public input on potential qualifying medical conditions and delivery methods for medical cannabis. Minnesotans submitted petitions in June and July. Following that, the process moved into a public comment period and a review panel.  

No petitions for new delivery methods were submitted this year. Petitions for gastroparesis and opioid use disorder were not approved. Gastroparesis, or delayed gastric emptying, was not approved as a qualifying medical because research indicates that cannabis can make the condition worse. As for opioid use disorder, the health department heard from medical and mental health providers who recommended against approving opioid use disorder as a qualifying medical condition due to lack of evidence for its effectiveness and the availability of FDA-approved medications for treatment. 

Under state rules, patients certified for new qualifying medical conditions will become eligible to enroll in the state’s medical cannabis program on July 1, 2023, and receive medical cannabis from either of the state’s two medical cannabis manufacturers starting Aug. 1, 2023. As with other qualifying conditions, patients need advance certification from a participating Minnesota health care provider. 

(Source: Minnesota Department of Health) 

Join Us! 2023 Virtual Legislative Forum: December 16th, 2022 - MN Council on Disability